Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Breast Diseases × Aromatase Inhibitors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Sexuality 1 Polycystic Ovary Syndrome 1 Neoplasms, Hormone-Dependent 1 Luminal B/HER2-negative Breast Cancer 1 Infertility 1 Hormone-receptor-positive Breast Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Diseases 1 Advanced Breast Cancer 1

Interventions

pyrotinib 3 Docetaxel 3 Trastuzumab 2 Letrozole 2 Epirubicin 2 Doxorubicin 2 Cyclophosphamide 2 Capecitabine 2 palbociclib 1 exemestane 1 Vinorelbine 1 Tomography, X-Ray Computed 1 Tamoxifen 1 Surgimend 1 Sodium Chloride 1 Paclitaxel 1 Mammaplasty 1 Liquid Biopsy 1 Lapatinib 1 Goserelin 1 Drug Therapy 1 Drug Evaluation 1 Cryotherapy 1 Carboplatin 1 Botulinum Toxins, Type A 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03910712 2019-04-10

Pyrotinib

Peking Union Medical College Hospital

Phase 2 Unknown

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡